Investors Sell Shares of Aetna Inc. (AET) on Strength (AET)

Investors sold shares of Aetna Inc. (NYSE:AET) on strength during trading hours on Wednesday. $60.33 million flowed into the stock on the tick-up and $120.59 million flowed out of the stock on the tick-down, for a money net flow of $60.26 million out of the stock. Of all equities tracked, Aetna had the 10th highest net out-flow for the day. Aetna traded up $1.53 for the day and closed at $157.43

AET has been the topic of several recent research reports. Zacks Investment Research upgraded shares of Aetna from a “hold” rating to a “buy” rating and set a $170.00 target price on the stock in a research report on Tuesday, July 4th. Citigroup Inc. started coverage on shares of Aetna in a research report on Wednesday, June 28th. They issued a “buy” rating and a $180.00 price target on the stock. BidaskClub lowered shares of Aetna from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 19th. Argus restated a “buy” rating and issued a $185.00 price target (up from $165.00) on shares of Aetna in a research report on Tuesday, September 12th. Finally, Deutsche Bank AG boosted their price target on shares of Aetna from $157.00 to $163.00 and gave the company a “hold” rating in a research report on Monday, August 7th. Nine investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $161.83.

The stock has a 50-day moving average price of $158.29 and a 200 day moving average price of $149.19. The company has a market cap of $52.28 billion, a P/E ratio of 34.95 and a beta of 0.53.

Aetna (NYSE:AET) last posted its quarterly earnings results on Thursday, August 3rd. The company reported $3.42 earnings per share for the quarter, beating analysts’ consensus estimates of $2.34 by $1.08. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The company had revenue of $15.52 billion for the quarter, compared to the consensus estimate of $15.34 billion. During the same period last year, the company posted $2.21 EPS. The firm’s quarterly revenue was down 2.7% compared to the same quarter last year. Equities research analysts anticipate that Aetna Inc. will post $9.56 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Thursday, October 12th will be paid a $0.50 dividend. The ex-dividend date is Wednesday, October 11th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.27%. Aetna’s payout ratio is currently 43.67%.

In other news, EVP Margaret M. Mccarthy sold 10,288 shares of the firm’s stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $162.85, for a total value of $1,675,400.80. Following the sale, the executive vice president now directly owns 33,563 shares in the company, valued at approximately $5,465,734.55. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, President Karen S. Lynch sold 15,271 shares of the firm’s stock in a transaction that occurred on Monday, September 18th. The shares were sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the completion of the sale, the president now owns 64,261 shares in the company, valued at $10,404,498.51. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Guardian Life Insurance Co. of America boosted its stake in shares of Aetna by 0.7% in the 1st quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock valued at $173,000 after purchasing an additional 9 shares in the last quarter. Financial Architects Inc boosted its position in Aetna by 1.8% during the 2nd quarter. Financial Architects Inc now owns 1,746 shares of the company’s stock worth $265,000 after buying an additional 31 shares during the period. Wedbush Securities Inc. boosted its position in Aetna by 1.4% during the 2nd quarter. Wedbush Securities Inc. now owns 3,779 shares of the company’s stock worth $574,000 after buying an additional 52 shares during the period. Calamos Wealth Management LLC boosted its position in Aetna by 0.7% during the 2nd quarter. Calamos Wealth Management LLC now owns 8,919 shares of the company’s stock worth $1,354,000 after buying an additional 65 shares during the period. Finally, HM Payson & Co. boosted its position in Aetna by 0.5% during the 1st quarter. HM Payson & Co. now owns 12,861 shares of the company’s stock worth $1,641,000 after buying an additional 69 shares during the period. Institutional investors own 89.52% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This article was first reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this article on another website, it was illegally copied and reposted in violation of United States and international copyright law. The legal version of this article can be read at https://www.chaffeybreeze.com/2017/10/18/investors-sell-shares-of-aetna-inc-aet-on-strength-aet.html.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply